Table 1.
Age at diagnosis, mean (range) | 69.6 years (36–93) |
Gender, male | 94 cases (80.3 %) |
pT stage at initial TUR | |
pTa | 92 cases (78.6 %) |
pT1 | 15 cases (12.8 %) |
pTis | 10 cases (8.6 %) |
Cellular grade at initial TUR | |
Low | 57 cases (48.7 %) |
High | 60 cases (51.3 %) |
Intravesical BCG therapy | 11 cases |
Intravesical chemotherapy (epirubicin) | 21 cases |
Total cystectomy | 16 cases |
Bladder cancer-specific mortality | 6 cases |
All-cause mortality | 21 cases |
BCG, Bacille Calmette–Guérin